Загрузка...
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up
Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (NIH) category II chronic bacterial prostatitis (CBP), therapy with these agents is not always feasible due to the increasing worldwide resistance of causative uropathogens. New therapeutic options are...
Сохранить в:
| Опубликовано в: : | Exp Ther Med |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038489/ https://ncbi.nlm.nih.gov/pubmed/27698761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3631 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|